Chapter 9 288 Gracia, C. R., Freeman, E. W., Sammel, M. D., Lin, H., Sheng, L., & Frye, C. (2009). Allopregnanolone Levels Before and After Selective Serotonin Reuptake Inhibitor Treatment of Premenstrual Symptoms. Journal of Clinical Psychopharmacology, 29(4), 403. https://doi.org/10.1097/JCP.0b013e3181ad8825 Guidotti, A., & Costa, E. (1998). Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3α, 5α- tetrahydroprogesterone (allopregnanolone) availability? Biological Psychiatry, 44(9), 865873. https://doi.org/10.1016/S0006-3223(98)00070-5 Hahn, L., Eickhoff, S. B., Habel, U., Stickeler, E., Schnakenberg, P., Goecke, T. W., Stickel, S., Franz, M., Dukart, J., & Chechko, N. (2021). Early identification of postpartum depression using demographic, clinical, and digital phenotyping. Translational Psychiatry, 11(1), Article 1. https://doi.org/10.1038/s41398-021-01245-6 Halbreich, U., Borenstein, J., Pearlstein, T., & Kahn, L. S. (2003). The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology, 28(SUPPL. 3), 1-23. https://doi.org/10.1016/S03064530(03)00098-2 Hamstra, D. A., de Kloet, E. R., de Rover, M., & Van der Does, W. (2017). Oral contraceptives positively affect mood in healthy PMS-free women: A longitudinal study. Journal of Psychosomatic Research, 103, 119-126. https://doi.org/10.1016/j.jpsychores.2017.10.011 Hamstra, D. A., de Kloet, E. R., van Hemert, A. M., de Rijk, R. H., & Van der Does, A. J. W. (2015). Mineralocorticoid receptor haplotype, oral contraceptives and emotional information processing. Neuroscience, 286, 412-422. https://doi.org/10.1016/j.neuroscience.2014. 12.004 Hamstra, D. A., De Rover, M., De Rijk, R. H., & Van der Does, W. (2014). Oral contraceptives may alter the detection of emotions in facial expressions. European Neuropsychopharmacology, 24(11), 1855-1859. https://doi.org/10.1016/j.euroneuro.2014.08.015 Hantsoo, L., & Epperson, C. N. (2020). Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiology of Stress, 12, 100213. https://doi.org/ 10.1016/j.ynstr.2020.100213 Harry-Hernandez, S., Reisner, S. L., Schrimshaw, E. W., Radix, A., Mallick, R., Callander, D., Suarez, L., Dubin, S., Khan, A., & Duncan, D. T. (2020). Gender Dysphoria, Mental Health, and Poor Sleep Health Among Transgender and Gender Nonbinary Individuals: A Qualitative Study in New York City. Transgender Health, 5(1), 59-68. https://doi.org/ 10.1089/trgh.2019.0007 Hartlage, S. A., Brandenburg, D. L., & Kravitz, H. M. (2004). Premenstrual Exacerbation of Depressive Disorders In a Community-Based Sample in the United States. Psychosomatic Medicine, 66(5), 698. https://doi.org/10.1097/01.psy.0000138131.92408.b9 Herrera, A. Y., Faude, S., Nielsen, S. E., Locke, M., & Mather, M. (2019). Effects of hormonal contraceptive phase and progestin generation on stress-induced cortisol and progesterone release. Neurobiology of Stress, 10, 100151. https://doi.org/10.1016/ j.ynstr.2019.100151 Hertel, J., König, J., Homuth, G., Van der Auwera, S., Wittfeld, K., Pietzner, M., Kacprowski, T., Pfeiffer, L., Kretschmer, A., Waldenberger, M., Kastenmüller, G., Artati, A., Suhre, K., Adamski, J., Langner, S., Völker, U., Völzke, H., Nauck, M., Friedrich, N., & Grabe, H. J. (2017). Evidence for Stress-like Alterations in the HPA-Axis in Women Taking Oral Contraceptives. Scientific Reports, 7(1), Article 1. https://doi.org/10.1038/s41598-01713927-7 Høgsted, E. S., Borgsted, C., Dam, V. H., Nasser, A., Rye Jørgensen, N., Ozenne, B., Stenbæk, D. S., & Frokjaer, V. G. (2021). Stress-Hormone Dynamics and Working Memory in Healthy Women Who Use Oral Contraceptives Versus Non-Users. Frontiers in Endocrinology, 12. https://www.frontiersin.org/articles/10.3389/fendo.2021.731994
RkJQdWJsaXNoZXIy MTk4NDMw